
News|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Improving Protein Capture for Transgenic Drug Processing
Author(s)Ian Sellick
One of the greatest challenges facing biopharmaceutical manufacturers has been the primary recovery of recombinant materials from transgenic sources. As an alternative to existing methods, vibrating membrane technology, which is widely used in food and beverage processing, recently has been adapted to biopharmaceutical applications involving transgenic biosolutions.
Advertisement
Articles in this issue
about 22 years ago
FDA Will Drive Changes for Contract Businessabout 22 years ago
In the Spotlight--Decemberabout 22 years ago
Novemember 2003about 22 years ago
FDA Seeks Risk-Based Inspection Programabout 22 years ago
Routine Sample Size for a Retest Procedureabout 22 years ago
November 2003about 22 years ago
Clearing Regulatory HurdlesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Building the Foundations for Proactive Drug Safety in 2026
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
Gene Therapy, Rare Diseases, and Transfer RNA
5




